All dMMR cases, excluding those with BRAF-V600E mutation or MLH1 promoter methylation (rarely reported in LS-related tumors), should be tested for germline mutations in MMR genes to confirm their LS diagnosis [14,15,20,32,37,38]. The gene discussed is MLH1; the disease is Leigh syndrome.